These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 865586)

  • 1. Transfer of C3 nephritic factor from mother to fetus. Is C3 nephritic factor IgG?
    Davis AE; Arnaout MA; Alper CA; Rosen FS
    N Engl J Med; 1977 Jul; 297(3):144-5. PubMed ID: 865586
    [No Abstract]   [Full Text] [Related]  

  • 2. Partial lipodystrophy and glomerulonephritis without complement activation.
    Mery JP; Kourilsky O; Morel-Maroger L; Adam C
    N Engl J Med; 1978 May; 298(18):1034. PubMed ID: 643001
    [No Abstract]   [Full Text] [Related]  

  • 3. Human glomerulonephritis and the C3 nephritic factor (C3NeF).
    Berthoux FC; Carpenter CB; Freyria AM; Traeger J; Merrill JP
    Clin Nephrol; 1976 Mar; 5(3):93-100. PubMed ID: 57022
    [No Abstract]   [Full Text] [Related]  

  • 4. C3 nephritic factor and hypocomplementaemia in a clinically healthy individual.
    Gewurz AT; Imherr SM; Strauss S; Gewurz H; Mold C
    Clin Exp Immunol; 1983 Oct; 54(1):253-8. PubMed ID: 6616970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of nephritic factor on C3 and on the terminal pathway of complement in vivo and in vitro.
    Mollnes TE; Ng YC; Peters DK; Lea T; Tschopp J; Harboe M
    Clin Exp Immunol; 1986 Jul; 65(1):73-9. PubMed ID: 3641694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nephritic factor, C3 splitting activity, C3 and factor B breakdown products in glomerular diseases.
    De Vecchi A; Montagnino G; Scalia P; Tarantino A
    Ric Clin Lab; 1980; 10(1):93-7. PubMed ID: 6781054
    [No Abstract]   [Full Text] [Related]  

  • 7. [Persistent C4 deficiency in a 26-month-old girl with mesangial glomerulonephritis and deposits of IgG and C3].
    Buffatti G; Borgo G; Lupo A
    Minerva Pediatr; 1977 Mar; 29(9):593-8. PubMed ID: 876007
    [No Abstract]   [Full Text] [Related]  

  • 8. The complement abnormalities of lipodystrophy.
    Sissons JG; West RJ; Fallows J; Williams DG; Boucher BJ; Amos N; Peters DK
    N Engl J Med; 1976 Feb; 294(9):461-5. PubMed ID: 1246331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C3 nephritic factor and C4 nephritic factor in the serum of two patients with hypocomplementaemic membranoproliferative glomerulonephritis.
    Tanuma Y; Ohi H; Watanabe S; Seki M; Hatano M
    Clin Exp Immunol; 1989 Apr; 76(1):82-5. PubMed ID: 2736802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Editorial: Glomerulonephritis, complement and C3NeF.
    Fearon DT
    N Engl J Med; 1976 Feb; 294(9):495-7. PubMed ID: 1246336
    [No Abstract]   [Full Text] [Related]  

  • 11. Identification of nephritic factor as an immunoglobulin.
    Williams DG; Bartlett A; Duffus P
    Clin Exp Immunol; 1978 Sep; 33(3):425-9. PubMed ID: 104814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Partial lipodystrophy, hypocomplementemia and glomerulonephritis].
    Habib R; Lévy M; Gubler MC; Broyer M; Habib M
    Arch Fr Pediatr; 1977; 34(7 Suppl):CXCVII-CCXII. PubMed ID: 931525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial lipodystrophy, C3 nephritic factor and clinically inapparent mesangiocapillary glomerulonephritis.
    Bennett WM; Bardana EJ; Wuepper K; Houghton D; Border WA; Götze O; Schreiber R
    Am J Med; 1977 May; 62(5):757-60. PubMed ID: 860726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological significance of the C3 nephritic factor in membranoproliferative glomerulonephritis.
    Schena FP; Pertosa G; Stanziale P; Vox E; Pecoraro C; Andreucci VE
    Clin Nephrol; 1982 Nov; 18(5):240-6. PubMed ID: 7151338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C3 nephritic factor (C3NeF): dissociation of cell-bound and fluid phase stabilization of alternative pathway C3 convertase.
    Ng YC; Peters DK
    Clin Exp Immunol; 1986 Aug; 65(2):450-7. PubMed ID: 3641695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Progress in the knowledge of complement. II. Nephritic factors].
    Leibowitch J; Lesavre P
    Nouv Presse Med; 1979 Jul; 8(30):2447-8. PubMed ID: 493036
    [No Abstract]   [Full Text] [Related]  

  • 17. The C3 nephritic factor (C3NeF) and the heat labile complement inactivator (HLCI) in chronic hypocomplementemic mesangioproliferative glomerulonephritis.
    Berthoux FC; Carpenter CB; Traeger J; Merrill JP
    Adv Nephrol Necker Hosp; 1974; 4():91-108. PubMed ID: 4220002
    [No Abstract]   [Full Text] [Related]  

  • 18. Novel C3 nephritic factor activity in the glomerulonephritis of staphylococcal endocarditis.
    Craddock CF; Richards NP; Powell RJ; Morgan AG
    Q J Med; 1987 Nov; 65(247):895-8. PubMed ID: 3455546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Concentration of C3 and C4 in the maternal blood and umbilical cord blood].
    Priolisi A; Liotta A; Damiani S
    Minerva Pediatr; 1977 Mar; 29(10):673. PubMed ID: 875935
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunoglobulin G and complement C3 levels in pregnancy induced hypertension.
    Ramdenee GR; Matah M; Bhatia BD; Sen MR; Swain S
    Indian Pediatr; 1995 Feb; 32(2):179-83. PubMed ID: 8635779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.